Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV001256740 | SCV001433146 | benign | not specified | 2020-03-04 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002064830 | SCV002421743 | likely benign | Hypertrophic cardiomyopathy 14 | 2024-02-23 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004027869 | SCV005018959 | likely benign | Cardiovascular phenotype | 2024-02-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV004704254 | SCV005211381 | likely benign | not provided | criteria provided, single submitter | not provided |